Search research articles
Contact Us
Filters
Showing results (71-80 of 120) with videos related to
Page
of 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2000
Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil. Groupe Français d'Immunothérapie, Fédération Nationale des Centres de Lutte Contre le Cancer
S Négrier, A Caty, T Lesimple, et al.
FEBS Letters
|
December 27, 1995
Interleukin-10 induces interleukin-11 responsiveness in human myeloma cell lines
Z Y Lu, Z J Gu, X G Zhang, et al.
Clinical and Experimental Immunology
|
November 1, 1994
Human anti-mouse antibody response to the injection of murine monoclonal antibodies against IL-6
E Legouffe, J Liautard, J P Gaillard, et al.
The American Journal of Surgical Pathology
|
November 1, 1990
Further phenotypic evidence that nodular, lymphocyte-predominant Hodgkin's disease is a large B-cell lymphoma in evolution
S M Chittal, C Alard, J F Rossi, et al.
Experimental Hematology
|
August 1, 1996
A ciliary neurotrophic factor-sensitive human myeloma cell line
Z J Gu, X G Zhang, M M Hallet, et al.
International Journal of Cancer
|
July 29, 1997
Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma
J Y Blay, J F Rossi, J Wijdenes, et al.
British Journal of Haematology
|
April 12, 2000
Spontaneous monoclonal immunoglobulin-secreting peripheral blood mononuclear cells as a marker of disease severity in multiple myeloma
F Cordoba, T Lavabre-Bertrand, S L Salhi, et al.
Blood
|
June 17, 1998
A gp130 interleukin-6 transducer-dependent SCID model of human multiple myeloma
C Rebouissou, J Wijdenes, P Autissier, et al.
Biotechniques
|
July 26, 2002
Multiplex fluorescent RT-PCR to quantify leukemic fusion transcripts
M Dupont, A Goldsborough, T Levayer, et al.
British Journal of Haematology
|
April 8, 1998
The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells
M Jourdan, M Ferlin, E Legouffe, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 120) with videos related to
Sort By:
Page
of 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2000
Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil. Groupe Français d'Immunothérapie, Fédération Nationale des Centres de Lutte Contre le Cancer
S Négrier, A Caty, T Lesimple, et al.
FEBS Letters
|
December 27, 1995
Interleukin-10 induces interleukin-11 responsiveness in human myeloma cell lines
Z Y Lu, Z J Gu, X G Zhang, et al.
Clinical and Experimental Immunology
|
November 1, 1994
Human anti-mouse antibody response to the injection of murine monoclonal antibodies against IL-6
E Legouffe, J Liautard, J P Gaillard, et al.
The American Journal of Surgical Pathology
|
November 1, 1990
Further phenotypic evidence that nodular, lymphocyte-predominant Hodgkin's disease is a large B-cell lymphoma in evolution
S M Chittal, C Alard, J F Rossi, et al.
Experimental Hematology
|
August 1, 1996
A ciliary neurotrophic factor-sensitive human myeloma cell line
Z J Gu, X G Zhang, M M Hallet, et al.
International Journal of Cancer
|
July 29, 1997
Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma
J Y Blay, J F Rossi, J Wijdenes, et al.
British Journal of Haematology
|
April 12, 2000
Spontaneous monoclonal immunoglobulin-secreting peripheral blood mononuclear cells as a marker of disease severity in multiple myeloma
F Cordoba, T Lavabre-Bertrand, S L Salhi, et al.
Blood
|
June 17, 1998
A gp130 interleukin-6 transducer-dependent SCID model of human multiple myeloma
C Rebouissou, J Wijdenes, P Autissier, et al.
Biotechniques
|
July 26, 2002
Multiplex fluorescent RT-PCR to quantify leukemic fusion transcripts
M Dupont, A Goldsborough, T Levayer, et al.
British Journal of Haematology
|
April 8, 1998
The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells
M Jourdan, M Ferlin, E Legouffe, et al.
Page
of 12